Recently, it was shown in a CKD-mediated cardiac hypertrophy model that FGF23 exerts its pro-hypertrophic action in cardiomyocytes by Klotho-independent signalling through FGFR425, 35. This evidence concerns the gene FGF23 and chronic kidney disease.